A
ARQT
Arcutis Biotherapeutics, Inc.
23.89
+0.51+2.16%After Hours: 23.89 0.00 0.00%19:30 09/11 EDT
OPEN/PREV CLOSE23.63/23.38
TODAY RANGE23.55-24.18
VOL2.04M
MARKET CAP3.00B
52 WEEK RANGE16.57-31.77
AVG VOL (3M)1.74M
% TURNOVER1.63%
TURNOVER--
P/E (TTM)111.35
% RANGE2.52%
EPS(TTM)0.2145
P/E(FORWARD)61.51
P/B13.60
BVPS1.756
DIVIDEND--
P/S7.83
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP2.66B
SHARES OUTSTANDING125.69M
NEXT EARNINGS10/26-10/30
FREE FLOAT111.18M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·6d ago
The Trade Desk to leave S&P 500 as Bloom Energy, Everpure, Illumina join index
Seeking Alpha·09/04 22:20
Bloom Energy surges on inclusion to S&P 500; Illumina, Everpure also added
TipRanks·09/04 21:50
S&P 600 adding ten companies at open on 9/21
TipRanks·08/29 02:05
Top Arcutis Insider Makes Major Move in High-Value Stock Sale
Simply Wall St·08/27 15:31
Is Arcutis Biotherapeutics (ARQT) Stock Too Rich To Stay Reasonable?
NASDAQ·08/27 08:27
Zacks Industry Outlook Halozyme, Repligen, Iovance, Arcutis and Precigen
NASDAQ·08/26 14:19
5 Biotech Stocks Worth Adding to Your Portfolio Now
TipRanks·08/25 02:11
Insider Move at Arcutis Biotherapeutics Sends Strong Signal to Investors
TipRanks·08/22 02:09
Top Arcutis Executive Makes Notable Move With Latest Stock Sale
TipRanks·08/21 16:33
Arcutis-Backed Phase 3 ZORYVE Foam Study Targets Growth in Seborrheic Dermatitis
TipRanks·08/20 17:30
Arcutis says Health Canada approves Zoryve cream 0.05% for children with AD
Simply Wall St·08/19 03:33
Arcutis Biotherapeutics (ARQT) Could Be 28% Undervalued As Profit And Guidance Improve